{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:38Z","timestamp":1759048178353,"version":"3.44.0"},"reference-count":18,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,6,5]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>Drug-induced thrombocytopenia (DITP) is suggested by severe thrombocytopenia with subsequent recovery of platelet count after removal of the offending drug. The diagnosis is ascertained when there is reproducibility of thrombocytopenia with repeated exposure. Filgrastim is used during peripheral blood progenitor cell harvest during autologous stem cell transplantation in the setting of multiple myeloma to prolong event-free survival and overall mortality. The following case illustrates all of the suggestive features of DITP after filgrastim exposure during elective stem cell harvest. Due to the inability to tolerate filgrastim, autologous stem cell transplant was aborted in this patient and he was maintained on induction chemotherapy.<\/jats:p>","DOI":"10.1136\/bcr-2020-234584","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T15:54:38Z","timestamp":1593532478000},"page":"e234584","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Filgrastim induced thrombocytopenia"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7386-7030","authenticated-orcid":false,"given":"Ghazal","family":"Kango","sequence":"first","affiliation":[{"name":"George Washington University, Washington, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faysal","family":"Haroun","sequence":"additional","affiliation":[{"name":"George Washington University, Washington, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"2025082708090117000_13.6.e234584.1","unstructured":"Viklund A . Platelets on the Web [Internet]. Platelets. Department of Biostatistics & Epidemiology, College of Public Health, OUHSC, 2019. https:\/\/www.ouhsc.edu\/platelets\/ditp.html"},{"key":"2025082708090117000_13.6.e234584.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03360.x"},{"key":"2025082708090117000_13.6.e234584.3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/bmt.2008.310","article-title":"G-Csf-Induced thrombocytopenia in a healthy donor","volume":"43","author":"Minelli","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"2025082708090117000_13.6.e234584.4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.transci.2018.10.002","article-title":"Severe thrombocytopenia related to filgrastim mobilization in a healthy donor","volume":"57","author":"Iltar","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"2025082708090117000_13.6.e234584.5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.4.471"},{"key":"2025082708090117000_13.6.e234584.6","doi-asserted-by":"crossref","first-page":"1014-6","DOI":"10.1002\/pbc.22315","article-title":"Granulocyte colony stimulating factor in neonatal alloimmune neutropenia: a possible association with induced thrombocytopenia","volume":"54","author":"Wiedl","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"2025082708090117000_13.6.e234584.7","first-page":"59","article-title":"Drug-Induced thrombocytopenia during G-CSF therapy in a patient with chronic neutropenia","volume":"23","author":"\u00d6zbek","year":"2006","journal-title":"Turk J Haematol"},{"key":"2025082708090117000_13.6.e234584.8","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-118-4-199302150-00030","article-title":"The Felty syndrome and G-CSF-associated thrombocytopenia and severe anemia","volume":"118","author":"Wun","year":"1993","journal-title":"Ann Intern Med"},{"key":"2025082708090117000_13.6.e234584.9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ajh.20787","article-title":"Profound thrombocytopenia related to G-CSF","volume":"82","author":"Kovacic","year":"2007","journal-title":"Am J Hematol"},{"key":"2025082708090117000_13.6.e234584.10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40261-013-0130-9","article-title":"Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a PEGylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjects","volume":"33","author":"Ahn","year":"2013","journal-title":"Clin Drug Investig"},{"key":"2025082708090117000_13.6.e234584.11","unstructured":"Neupogen (Filgrastim). Available: www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/103353s5147lbl.pdf"},{"key":"2025082708090117000_13.6.e234584.12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s10637-014-0068-7","article-title":"An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel PEGylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects","volume":"32","author":"Shin","year":"2014","journal-title":"Invest New Drugs"},{"key":"2025082708090117000_13.6.e234584.13","unstructured":"Gewirtz AM , Keating A , Thompson AA . Hematology 2009. Washington, DC: American Society of Hematology, 2009."},{"key":"2025082708090117000_13.6.e234584.14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-423939"},{"key":"2025082708090117000_13.6.e234584.15","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200109000-00005"},{"key":"2025082708090117000_13.6.e234584.16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1537-2995.1999.39199116893.x","article-title":"Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors","volume":"39","author":"Lane","year":"1999","journal-title":"Transfusion"},{"key":"2025082708090117000_13.6.e234584.17","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12285"},{"key":"2025082708090117000_13.6.e234584.18","doi-asserted-by":"crossref","unstructured":"Catley L , Anderson K . Autologous hematopoietic cell transplantation for multiple myeloma. Thomas Hematopoietic Cell Transplantation 2010:1262\u201382.","DOI":"10.1002\/9780470987070.ch92"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-234584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:09:13Z","timestamp":1756307353000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-234584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,30]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/bcr-2020-234584"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-234584","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}